Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Immunotherapy × Lymphoid × Clear all

Phase

Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 26 Thoracic 21 Head & Neck 6 Dermatologic 6 Breast 5 Gynecologic 4 Tumor-Agnostic 1 Sarcoma 1 Plasma cell 1 Lymphoid 1 Genitourinary 1 CNS 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1

Interventions

Rituximab 591 Cyclophosphamide 516 Etoposide 235 Vincristine 232 Doxorubicin 226 Cytarabine 195 Prednisone 185 Methotrexate 176 Filgrastim 161 fludarabine 152 Dexamethasone 151 fludarabine phosphate 150 Lenalidomide 141 Radiotherapy 114 Melphalan 106 Peripheral Blood Stem Cell Transplantation 101 Bendamustine Hydrochloride 101 Busulfan 100 Bortezomib 94 ibrutinib 93 Granulocyte Colony-Stimulating Factor 92 Mycophenolic Acid 91 venetoclax 89 obinutuzumab 86 Whole-Body Irradiation 86 Tacrolimus 77 Gemcitabine 76 zanubrutinib 69 Carmustine 63 Brentuximab Vedotin 63

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00558220 2007-11-14

R-MCEB

Czech Lymphoma Study Group

Phase 2 Completed

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡